Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Malignant Melanoma

Free Subscription 23.02.2026 2 Am J Dermatopathol 1 Ann Surg Oncol 1 BMC Cancer 1 Br J Cancer 1 Cancer 1 Cancer Lett 1 Cancer Res 2 Curr Opin Oncol 1 J Am Acad Dermatol 1 J Cell Physiol 1 J Clin Invest 1 N Engl J Med 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Dermatopathol

1. KISZLUK A, Alhalaseh YN, Asar MC, Chen F, et al
   Verhoeff-van Gieson May Distinguish Desmoplastic Melanoma From Re-Excision Scar.
   Am J Dermatopathol. 2026;48:193-196.
   PubMed         Abstract available
   
   
2. WRIGHT BB, Walters R, Googe P, Al-Rohil RN, et al
   Melanocytoma With Morphologic Features Reminiscent of BAP-1-Inactivated Melanocytoma but With a Different Molecular Profile.
   Am J Dermatopathol. 2026 Jan 2. doi: 10.1097/DAD.0000000000003209.
   PubMed         Abstract available
   
   

   
   Ann Surg Oncol

3. RIAZ N, Leong SP, Kashani-Sabet M, White RL Jr, et al
   Publisher Correction: Prognostic Value of Non-nodal Regional Metastases in Predicting Sentinel Lymph Node Status in Cutaneous Melanoma: Multicenter Analysis of the Sentinel Lymph Node Working Group Database.
   Ann Surg Oncol. 2026 Feb 16. doi: 10.1245/s10434-026-19230.
   PubMed        
   
   

   
   BMC Cancer

4. MOGHADAM A, Gill VT, Sabazade S, Hagstrom A, et al
   Independent validation of time to treatment as a prognostic factor in uveal melanoma.
   BMC Cancer. 2026 Feb 19. doi: 10.1186/s12885-026-15775.
   PubMed        
   
   

   
   Br J Cancer

5. WOODFORD R, Lorigan P, Oudit D, Abdulgawad A, et al
   Tumour-infiltrating lymphocyte therapy in melanoma: ready for prime time?
   Br J Cancer. 2026 Feb 18. doi: 10.1038/s41416-026-03350.
   PubMed         Abstract available
   
   

   
   Cancer

6. ZAKHARIA Y, Kim D, Freesmeier M, Frees M, et al
   A phase 1b/2 study of cabozantinib in combination with pembrolizumab in advanced cutaneous melanoma.
   Cancer. 2026;132:e70326.
   PubMed         Abstract available
   
   

   
   Cancer Lett

7. FU Y, Jiang C, Chen Y, Li F, et al
   Pharmacological inhibition of histone deacetylase 6 and DNA damage repair enhances radiosensitivity in melanoma.
   Cancer Lett. 2026 Feb 17:218322. doi: 10.1016/j.canlet.2026.218322.
   PubMed         Abstract available
   
   

   
   Cancer Res

8. RONDEAU V, Bansal S, Buttigieg MM, Zeng AGX, et al
   Response to Immune Checkpoint Blockade Is Enhanced in the Presence of Hematopoietic TET2 Inactivation.
   Cancer Res. 2026;86:845-857.
   PubMed         Abstract available
   
   

   
   Curr Opin Oncol

9. BOUSSINGAULT L, Mtimet L, Suppa M
   Noninvasive skin imaging of melanocytic and nonmelanocytic tumours: recent findings.
   Curr Opin Oncol. 2026;38:95-101.
   PubMed         Abstract available
   
   
10. ABBOUD S, Romano L, Langouo Fontsa M
    Melanoma in adolescents and young adults: special considerations.
    Curr Opin Oncol. 2026;38:89-94.
    PubMed         Abstract available
    
    

    
    J Am Acad Dermatol

11. DRISCOLL CB, Schwab G, Quan VL, McKenney J, et al
    Tumor necrosis alpha inhibitor therapy is associated with increased long-term risk of non-melanoma skin cancer and melanoma: a retrospective cohort study.
    J Am Acad Dermatol. 2026 Feb 16:S0190-9622(26)00231.
    PubMed         Abstract available
    
    

    
    J Cell Physiol

12. HEO HH, Youn H, Moon EY, Um SJ, et al
    Epigenetic Silencing of Primary Cilia Genes by PRAME and ETS2 in Melanoma Cells.
    J Cell Physiol. 2026;241:e70151.
    PubMed         Abstract available
    
    

    
    J Clin Invest

13. WU L, Wentworth JM, Liddle C, Fewings N, et al
    Pancreatic volume and immune biomarkers predict checkpoint inhibitor-associated autoimmune diabetes in humans.
    J Clin Invest. 2025 Nov 20:e192938. doi: 10.1172/JCI192938.
    PubMed         Abstract available
    
    

    
    N Engl J Med

14. 
    Nivolumab for Resected Stage III or IV Melanoma at 9 Years.
    N Engl J Med. 2026;394:832.
    PubMed        
    
    

    
    Proc Natl Acad Sci U S A

15. BAIRD MA, Jewett CE, Malide DA, Kratz L, et al
    Lamin B receptor upregulation in metastatic melanoma causes nuclear envelope fragility in confined migration during cancer invasion.
    Proc Natl Acad Sci U S A. 2026;123:e2513031123.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum